Former Chairman and Managing Partner, UK&I, EY, Joins to Support European Industrials and Business Services Group

London, 17 September 2025 – Warburg Pincus, the pioneer of private equity global growth investing, today announced the appointment of Steve Varley as Senior Advisor. Mr. Varley will support the firm’s Industrials and Business Services group, with a focus on professional services opportunities, and companies at the intersection of services and technology. He will also engage across the broader Warburg Pincus platform globally, contributing to the firm’s value creation and deal origination capabilities.

Mr. Varley brings over three decades of experience in professional services, with a proven track record of leading and transforming multi-billion-dollar businesses. He currently serves as Chairman of Unity Advisory, a next-generation CFO advisory firm and Warburg Pincus portfolio company. Most recently, he served as Global Vice Chair, Sustainability at EY, advising some of the world’s largest companies on long-term value creation through sustainability initiatives. Prior to that, he was Chairman and Managing Partner, UK&I at EY, leading over 20,000 professionals and driving the firm’s growth and innovation. He also held several other senior leadership roles across EY, including Managing Partner for Consulting in Northern Europe, the Middle East, India and Africa, and served on both the EMEIA Executive Board and the Global Practice Group, helping to shape the firm’s global strategy.

“I have long admired Warburg Pincus’s thesis-led approach, global and growth-oriented mindset, and long-term investment philosophy,” said Steve Varley. “Having worked with the team first-hand through my role in Unity Advisory, I’m excited to continue working with Warburg Pincus to identify and grow exceptional businesses in the services space, particularly as technology and innovation continue to reshape the industry.”

“Steve’s deep sector expertise, global leadership experience, and strong relationships across the services ecosystem make him an invaluable addition to Warburg Pincus,” said David Reis, Managing Director, Industrials and Business Services, Warburg Pincus. “He has been a trusted advisor to CEOs, Boards and government, and his insights will help shape our investment theses and deepen our reach in high-growth segments of the services ecosystem.”

Mr. Varley has held numerous advisory and non-executive positions throughout his career, including as a business advisor to two Prime Ministers and a Special Advisor to the United Nations. In addition to serving as Chairman of Unity Advisory, he also chairs the boards of DWF Group and Liverpool Football Club Foundation.

Media contact:

Alice Gibb
Director, Europe Communications
Alice.gibb@warburgpincus.com
+44 207 306 3090

About Warburg Pincus

Warburg Pincus LLC is the pioneer of global growth investing. A private partnership since 1966, the firm has the flexibility and experience to focus on helping investors and management teams achieve enduring success across market cycles. Today, the firm has more than $86 billion in assets under management, and more than 220 companies in their active portfolio, diversified across stages, sectors, and geographies. Warburg Pincus has invested in more than 1,000 companies across its private equity, real estate, and capital solutions strategies

The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, São Paulo, Shanghai, and Singapore. For more information, please visit www.warburgpincus.com or follow us on LinkedIn.

CVC announces the appointment of Bruce Hamilton, who will be joining as Head of Investor Relations.

Bruce is a senior equity research analyst with over twenty-five years’ experience covering the European Financials Sector. He joins CVC from Morgan Stanley where he headed the Diversified Financials team, covering asset managers, private markets managers, exchanges and investment platforms.

London, 9 September 2025 – Alantra, the independent global mid-market financial services firm, has strengthened its Technology Investment Banking practice with the appointment of Ed Wirgman as Managing Director. Joining from Houlihan Lokey, where he was a Managing Director in the European Technology Group, Ed brings over 20 years of M&A advisory experience and has worked extensively across a range of Technology subsectors. During his career, he has advised large multinationals, Private Equity investors, and founder-owners on numerous sales, acquisitions, and fundraisings.

Based in London, Ed will work closely with Alantra’s global Technology team to advise clients in IT Services, Technology Consulting and Software, with particular focus on services-led businesses.

Prior to Houlihan Lokey, Ed was a Managing Director at Oakley Advisory and Head of TMT at Spectrum Corporate Finance, the largest independent corporate finance boutique in the South of England at the time. Earlier in his career, he spent a decade at KPMG, culminating in leading the TMT Corporate Finance group nationally.

This strategic hire underscores Alantra’s commitment to growing its global Technology practice by adding senior sector specialists and continuing to strengthen its presence across key hubs in Europe and the U.S. In the last year, Alantra’s global Technology team has advised on 18 transactions with a combined value in excess of €1.1bn, and comprises 40 members based in the UK, the U.S., Spain, Germany, France and the Nordics. Notable recent transactions include the sale of Sincera to Virtusa, the sale of SpearMC to Mythics and the sale of Newport Capital backed TDA Group to The Relevance Group.

Flexpoint Ford, a specialist private equity firm focused on financial services and complementary industries, including business and healthcare services, announced today that Steve Baranowski has joined the Firm as Chief Financial Officer, based in the Chicago office.

Mr. Baranowski joins Flexpoint from Adams Street Partners, where he most recently served as Partner and Head of Client Operations. In that role, he led a team of more than 50 professionals across investment accounting, middle office, tax, treasury operations, and performance reporting and analysis. Prior to joining Adams Street Partners, Mr. Baranowski served as a Tax Managing Director at KPMG, advising private equity, mutual funds, banking, and other investment fund clients. Mr. Baranowski holds an MBA from the University of Chicago Booth School of Business and a BBA from the University of Notre Dame.

“We are thrilled to welcome Steve to Flexpoint,” said Chris Ackerman, Managing Partner. “His deep expertise across operations, finance, and reporting will be instrumental in strengthening our fund administration infrastructure and advancing our mission to deliver growth and value to our investors and portfolio companies.”

“Steve’s leadership experience will be an asset to Flexpoint as we continue to grow,” added Don Edwards, Chief Executive Officer at Flexpoint. His ability to build strong teams and implement best-in-class processes will help ensure Flexpoint remains well-positioned for the future.”

“I am honored to join Flexpoint at such an exciting time in the Firm’s growth,” said Mr. Baranowski.  “I look forward to partnering with the leadership team to enhance our finance and operations capabilities and to support the continued success of our investors and portfolio companies.”

The Firm also announced that Steve Haworth, who has served as Chief Financial Officer since 2005, will continue in his role as Managing Director and assist Mr. Baranowski in his transition. Flexpoint is deeply grateful for his many contributions over the past two decades and is pleased that he will continue to provide leadership and guidance in the Firm’s next chapter.

BOSTON and LONDON, Sept. 3, 2025 /PRNewswire/ — Ampersand Capital Partners (“Ampersand”), a global private equity firm specializing in life sciences and healthcare growth investments, today announced the opening of a new office in London. The move further strengthens the firm’s European footprint, building on the success of its Amsterdam office launched in 2017.

As part of this expansion, Ampersand announced that Matthew Norton has joined the firm as a General Partner based in London, where he will lead its European efforts. Matt brings more than 15 years of healthcare private equity experience, most recently serving as a Partner at Cinven. In that role, he helped shape the firm’s healthcare strategy and led transformative growth initiatives across Europe and the United States.

In addition, Marina Pellon-Consunji. Partner will be relocating to London. Marina was instrumental in establishing Ampersand’s Amsterdam presence, leading multiple platform investments and add-on acquisitions across Europe. She will continue to drive these efforts from the new London office.

“We are pleased to announce the addition of Matthew Norton to Ampersand’s team, along with the opening of a London office,” said Herb Hooper, Managing Partner of Ampersand. “With Matt’s and Marina’s experience and leadership, we are well-positioned to continue identifying and scaling the next generation of global healthcare and life sciences companies.”

The new London office underscores Ampersand Capital Partners’ long-term commitment to building exceptional growth-stage companies worldwide. For more than 30 years, Ampersand has focused on building market-leading companies in the life sciences and healthcare sectors, by accelerating growth across lab products, lab services, contract manufacturing, pharma services, and specialty products companies. Together with its established offices in Boston and Amsterdam, the London presence positions Ampersand as a global leader in healthcare and life sciences private equity.

 

About Ampersand Capital Partners

Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With hubs in Boston, Amsterdam, and London, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors. For additional information, visit www.ampersandcapital.com or follow us on LinkedIn

GRAND RAPIDS, MI – September 2, 2025 – Grand River Aseptic Manufacturing (“GRAM” or the “Company”), a portfolio company of Arlington Capital Partners, today announced the promotion of Denis Johnson to Chief Executive Officer, effective September 1, 2025. Mr. Johnson has served as President of GRAM since March 31, 2025.

In this new role, Mr. Johnson will lead GRAM’s next phase of growth, driving strategic expansion, operational excellence, and deepened client engagement in the aseptic manufacturing space.

Mr. Johnson brings extensive life sciences leadership and manufacturing experience to this role including significant prior sterile fill-finish experience.   His prior roles include Head of Global Manufacturing and Technical Operations at Biogen as well as leadership roles at Catalent, Boston Scientific and Johnson & Johnson.  He started his career in the U.S. Army managing logistics and operations.

Matt Altman, Chairman of GRAM’s Board of Directors and a Managing Partner at Arlington Capital, commented, “Denis’s leadership as President has already accelerated GRAM’s strong growth through the successful onboarding of new clients and products. His operational acumen and strategic vision will enhance GRAM’s ability to scale effectively and continue delivering exceptional value to our clients as we move forward.”

Mr. Johnson brings significant leadership experience and an unwavering commitment to execution and client service.  He added, “I am honored to step into the role of CEO at GRAM. As we celebrate the company’s 15^th anniversary, I look forward to working with our talented team to expand our capabilities, enhance our service delivery, and uphold the high standards our clients expect.”

The Company also announced that Derek Hennecke, who has served as CEO since September 15, 2024, will return to GRAM’s Board of Directors. Mr. Altman added, “We thank Derek for his steadfast leadership during this transition and appreciate his ongoing guidance as he resumes his role on the Board.”

About Grand River Aseptic Manufacturing
Grand River Aseptic Manufacturing is a premier parenteral contract development and manufacturing organization (CDMO), offering clinical through commercial sterile manufacturing services. GRAM partners with pharmaceutical and biotechnology companies to bring life‑saving therapies to market, leveraging state‑of‑the‑art facilities, advanced technology, and deep technical expertise. For more information, visit www.grandriverasepticmfg.com and follow GRAM on LinkedIn.

About Arlington Capital Partners
Arlington Capital Partners is a Washington, D.C.-area private investment firm specializing in government-regulated industries. The firm partners with founders and management teams to build strategically important businesses in the government services and technology, aerospace and defense, and healthcare sectors. Since its inception in 1999, Arlington has invested in over 175 companies and is currently investing out of its $3.8 billion Fund VI. For more information, visit Arlington’s website at www.arlingtoncap.com and follow Arlington on LinkedIn.